Mgo One Seven LLC Bio Techne Corp Transaction History

Mgo One Seven LLC

$2.26 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $37,543 - $43,763	-509 Reduced 7.1%	6,655 $543,000
Q1 2023 May 08, 2023	SELL	$71.62 - $86.62 $71 - $86	-1 Reduced 0.01%	7,164 $531,000
Q4 2022 Jan 25, 2023	BUY	$80.67 - $352.29 $209,015 - $912,783	2,591 Added 56.65%	7,165 $0
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $1.29 Million - $1.79 Million	4,574 New	4,574 $1.3 Million
Q1 2021 Apr 29, 2021	SELL	$314.62 - $411.0 $299,832 - $391,683	-953 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$246.9 - $321.87 $19,011 - $24,783	-77 Reduced 7.48%	953 $303,000
Q3 2020 Oct 30, 2020	SELL	$232.22 - $282.96 $23,222 - $28,295	-100 Reduced 8.85%	1,030 $255,000
Q2 2020 Aug 12, 2020	SELL	$185.43 - $279.56 $7,046 - $10,623	-38 Reduced 3.25%	1,130 $298,000
Q1 2020 Apr 17, 2020	SELL	$161.17 - $221.51 $32,556 - $44,745	-202 Reduced 14.74%	1,168 $221,000
Q4 2019 Jan 16, 2020	SELL	$189.68 - $222.09 $9,484 - $11,104	-50 Reduced 3.52%	1,370 $300,000
Q3 2019 Oct 10, 2019	BUY	$183.56 - $216.72 $183 - $216	1 Added 0.07%	1,420 $278,000
Q2 2019 Jul 16, 2019	SELL	$188.72 - $215.43 $42,084 - $48,040	-223 Reduced 13.58%	1,419 $295,000
Q1 2019 Apr 09, 2019	BUY	$136.09 - $200.44 $108,872 - $160,352	800 Added 95.01%	1,642 $326,000
Q4 2018 Jan 24, 2019	BUY	$132.75 - $203.8 $111,775 - $171,599	842 New	842 $121,000
Q3 2018 Oct 09, 2018	SELL	$147.44 - $204.11 $136,234 - $188,597	-924 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $85,843 - $98,629	653 Added 240.96%	924 $140,000
Q4 2017 Feb 16, 2018	BUY	$121.17 - $134.75 $32,837 - $36,517	271	271 $35,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account